Yaron Werber
Stock Analyst at TD Cowen
(4.96)
# 111
Out of 4,662 analysts
772
Total ratings
61.7%
Success rate
30.4%
Average return
Main Sectors:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Reiterated: Buy | $1,146 → $1,353 | $1,032.86 | +31.00% | 56 | Aug 17, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $325 → $341 | $259.62 | +31.35% | 28 | Aug 13, 2026 | |
| KLRA Kailera Therapeutics | Reiterated: Buy | $57 | $18.32 | +211.14% | 5 | Aug 13, 2026 | |
| LEGN Legend Biotech | Rated: Hold | $29 → $24 | $22.60 | +6.19% | 20 | Aug 12, 2026 | |
| SEPN Septerna | Maintained: Buy | n/a | $43.93 | - | 8 | Aug 11, 2026 | |
| GMAB Genmab | Rated: Buy | $43 | $34.11 | +26.06% | 26 | Aug 7, 2026 | |
| ALEC Alector | Maintained: Hold | n/a | $2.43 | - | 25 | Aug 6, 2026 | |
| RLAY Relay Therapeutics | Maintained: Buy | n/a | $20.74 | - | 19 | Aug 6, 2026 | |
| ROIV Roivant Sciences | Maintained: Buy | $29 → $50 | $37.40 | +33.69% | 26 | Aug 6, 2026 | |
| AMGN Amgen | Reiterated: Buy | $326 → $452 | $442.36 | +2.18% | 72 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $54.39 | +1.12% | 35 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $424 → $454 | $376.86 | +20.47% | 45 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $150 | $113.70 | +31.93% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $49 | $26.24 | +86.74% | 44 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $33.03 | +81.65% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 | $60.80 | +54.61% | 43 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $77 | $76.90 | +0.13% | 9 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.26 | - | 19 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $227 | $273.41 | -17.08% | 1 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.7466 | - | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $23.58 | - | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.52 | - | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.28 | - | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $27.21 | - | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $41.70 | - | 14 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.06 | - | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $94 | $113.12 | -16.90% | 28 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.51 | - | 6 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | - | 12 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.54 | - | 11 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $359.76 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €664.00 | €881.20 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2,152.00 | n/a | 1 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.33 | n/a | 4 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $50.30 | n/a | 1 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $3 | $7.15 | n/a | 6 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.39 | n/a | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $684 → $565 | $840.84 | n/a | 30 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $11.31 | n/a | 1 | Dec 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.65 | n/a | 10 | Aug 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.25 | n/a | 6 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.42 | n/a | 6 | Dec 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $36.85 | n/a | 4 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $497 → $345 | $221.56 | n/a | 16 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 → $110 | $147.60 | n/a | 13 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $266 → $94 | $9.49 | n/a | 5 | Sep 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $137 → $132 | $35.12 | n/a | 2 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $37 | $9.60 | n/a | 1 | Nov 10, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $19.73 | n/a | 3 | Apr 22, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5 | $46.96 | n/a | 5 | Jun 4, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $100 | $552.06 | n/a | 7 | Apr 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $0.0001 | n/a | 1 | Mar 12, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $52.88 | n/a | 1 | Nov 17, 2010 |
argenx SE
Aug 17, 2026
Reiterated: Buy
Price Target: $1,146 → $1,353
Current: $1,032.86
Upside: +31.00%
Ascendis Pharma
Aug 13, 2026
Maintained: Buy
Price Target: $325 → $341
Current: $259.62
Upside: +31.35%
Kailera Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $57
Current: $18.32
Upside: +211.14%
Legend Biotech
Aug 12, 2026
Rated: Hold
Price Target: $29 → $24
Current: $22.60
Upside: +6.19%
Septerna
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $43.93
Upside: -
Genmab
Aug 7, 2026
Rated: Buy
Price Target: $43
Current: $34.11
Upside: +26.06%
Alector
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $2.43
Upside: -
Relay Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $20.74
Upside: -
Roivant Sciences
Aug 6, 2026
Maintained: Buy
Price Target: $29 → $50
Current: $37.40
Upside: +33.69%
Amgen
Aug 5, 2026
Reiterated: Buy
Price Target: $326 → $452
Current: $442.36
Upside: +2.18%
Aug 5, 2026
Maintained: Buy
Price Target: $55
Current: $54.39
Upside: +1.12%
Aug 5, 2026
Maintained: Buy
Price Target: $424 → $454
Current: $376.86
Upside: +20.47%
Aug 5, 2026
Rated: Buy
Price Target: $150
Current: $113.70
Upside: +31.93%
Aug 4, 2026
Rated: Buy
Price Target: $49
Current: $26.24
Upside: +86.74%
Aug 4, 2026
Reiterated: Buy
Price Target: $60
Current: $33.03
Upside: +81.65%
Jul 29, 2026
Maintained: Buy
Price Target: $94
Current: $60.80
Upside: +54.61%
Jul 27, 2026
Downgraded: Hold
Price Target: $77
Current: $76.90
Upside: +0.13%
Jun 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.26
Upside: -
May 18, 2026
Maintained: Buy
Price Target: $227
Current: $273.41
Upside: -17.08%
May 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.7466
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $23.58
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $7.52
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $1.28
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $27.21
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $41.70
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $7.06
Upside: -
May 5, 2026
Maintained: Hold
Price Target: $94
Current: $113.12
Upside: -16.90%
Apr 21, 2026
Downgraded: Hold
Price Target: n/a
Current: $4.51
Upside: -
Mar 31, 2026
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: -
Mar 26, 2026
Maintained: Buy
Price Target: n/a
Current: $2.54
Upside: -
May 21, 2025
Reiterated: Buy
Price Target: $230
Current: $359.76
Upside: n/a
Feb 21, 2025
Maintained: Buy
Price Target: €664.00
Current: €881.20
Upside: n/a
Apr 3, 2024
Maintained: Hold
Price Target: n/a
Current: $2,152.00
Upside: n/a
Mar 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $5.33
Upside: n/a
Mar 11, 2024
Maintained: Buy
Price Target: n/a
Current: $50.30
Upside: n/a
Jun 26, 2023
Maintained: Hold
Price Target: $25 → $3
Current: $7.15
Upside: n/a
Nov 1, 2022
Downgraded: Hold
Price Target: n/a
Current: $7.39
Upside: n/a
Feb 8, 2021
Maintained: Hold
Price Target: $684 → $565
Current: $840.84
Upside: n/a
Dec 14, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $11.31
Upside: n/a
Aug 5, 2020
Maintained: Buy
Price Target: n/a
Current: $3.65
Upside: n/a
Feb 21, 2020
Rated: Hold
Price Target: n/a
Current: $4.25
Upside: n/a
Dec 31, 2019
Maintained: Hold
Price Target: n/a
Current: $5.42
Upside: n/a
Aug 12, 2019
Maintained: Hold
Price Target: n/a
Current: $36.85
Upside: n/a
Feb 25, 2016
Rated: Buy
Price Target: $497 → $345
Current: $221.56
Upside: n/a
Feb 25, 2016
Initiated Coverage: Buy
Price Target: $120 → $110
Current: $147.60
Upside: n/a
Sep 3, 2015
Initiated Coverage: Buy
Price Target: $266 → $94
Current: $9.49
Upside: n/a
Feb 18, 2015
Maintained: Hold
Price Target: $137 → $132
Current: $35.12
Upside: n/a
Nov 10, 2014
Initiated Coverage: Buy
Price Target: $37
Current: $9.60
Upside: n/a
Apr 22, 2014
Upgraded: Hold
Price Target: n/a
Current: $19.73
Upside: n/a
Jun 4, 2013
Maintained: Hold
Price Target: $7 → $5
Current: $46.96
Upside: n/a
Apr 19, 2013
Maintained: Buy
Price Target: $63 → $100
Current: $552.06
Upside: n/a
Mar 12, 2012
Downgraded: Hold
Price Target: $3
Current: $0.0001
Upside: n/a
Nov 17, 2010
Downgraded: Hold
Price Target: n/a
Current: $52.88
Upside: n/a